AMPIO PHARMACEUTICALS
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the potential to be safe and effective for improving patient care. The company’s product pipeline includes new uses for approved drugs and new molecular entities (“NMEs”) for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. Central to the company’s successful clinical development programs ar... e its strong relationships with clinicians, academic medical centers, regional hospitals and specialized product and service providers. A phase II clinical development program is underway in addition to sponsored basic, translational and clinical research projects aimed at specific disease mechanisms. The company has built a robust portfolio of issued patents and pending patent applications on its products.
AMPIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Greenwood Village, Colorado, United States
Country:
United States
Website Url:
http://www.ampiopharma.com
Total Employee:
11+
Status:
Active
Contact:
720-437-6500
Email Addresses:
[email protected]
Total Funding:
75.89 M USD
Technology used in webpage:
Google Maps IPv6 Microsoft Cogent Communications
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
GlycoMimetics
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.ampiopharma.com Semrush global rank: 13.11 M Semrush visits lastest month: 78
- Host name: 3.246.109.208.host.secureserver.net
- IP address: 208.109.246.3
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ampio Pharmaceuticals"
Ampio Pharmaceuticals - Ampio Pharmaceuticals
Stipulation and Agreement of Settlement, dated January 8, 2025. Notice of Proposed Derivative Settlement, dated January 21, 2025. Dear Ampio Stockholders:See details»
Ampio Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 720-437-6500 Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs selected from its extensive portfolio with the …See details»
Ampio Pharmaceuticals (AMPE) Profile - The Globe and Mail
Mar 25, 2024 See the company profile for Ampio Pharmaceuticals (AMPE) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Ampio Pharmaceuticals, Inc. | LinkedIn
Ampio Pharmaceuticals, Inc. | 603 followers on LinkedIn. Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at ...See details»
Ampio Pharmaceuticals, Inc. (AMPE)
See the company profile for Ampio Pharmaceuticals, Inc. (AMPE) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Ampio Pharmaceuticals, Inc. - Dun & Bradstreet
Company Description: With hopes one day of taking in revenues somewhere between ample and copious, Ampio Pharmaceuticals is a development-stage company that focuses on …See details»
Ampio Provides Litigation Update Reports Settlement in Principle …
ENGLEWOOD, Colo., January 11, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), a pre-revenue stage biopharmaceutical company focused on …See details»
Ampio Pharmaceuticals Company Description - Stock Analysis
Company profile for Ampio Pharmaceuticals, Inc. (AMPE) with a description, list of executives, contact details and other key facts.See details»
Ampio Letter to Stockholders - Ampio ... - Ampio Pharmaceuticals
ENGLEWOOD, Colo., August 3, 2022 — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief …See details»
Ampio Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed …See details»
Ampio Pharmaceuticals
Feb 25, 2025 Ampio Pharmaceuticals, Inc. was founded in 2004 with a mission to develop unique drugs derived from plants for the treatment of a broad range of diseases.See details»
AMPE - Ampio Pharmaceuticals, Inc. | Company Profile | OTC …
Ampiopharma.com +1 (720) 437-6500. [email protected]. Last Verified 12/2023. Business Description. Ampio Pharmaceuticals, Inc. is a pre-revenue stage biopharmaceutical company …See details»
Ampio Pharmaceuticals - Craft
Oct 29, 2024 Ampio Pharmaceuticals has 5 employees at their 1 location and $50 k in annual revenue in FY 2013. See insights on Ampio Pharmaceuticals including office locations, …See details»
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
ENGLEWOOD, Colo., Jan. 17, 2023 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company”) today released the following letter to stockholders from its Chairman, Kevin …See details»
Ampio Pharmaceuticals - Overview, News & Similar companies
Who is Ampio Pharmaceuticals. Ampio Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the advancement of immunology-based therapies to treat common infla …See details»
Ampio Pharmaceuticals Strengthens Management Team and …
ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory …See details»
Ampio Pharmaceuticals, Inc. (AMPE) - Yahoo Finance Canada
Find the latest Ampio Pharmaceuticals, Inc. (AMPE) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO …
Ascendia, a specialty contract development and manufacturing organization (CDMO) leader, will provide Ampio with a range of services including formulation development, process …See details»
Amplio Pharma Company Profile 2025: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Amplio Pharma. Use the PitchBook Platform to explore the full profile.See details»
Ampio Pharmaceuticals Issues Letter to Stockholders
Proposal to Authorize Reverse Stock Split has Been Approved ENGLEWOOD, Colo., October 14, 2022 — Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), today released the …See details»